“Sales are rising by an average 8% from one month to the next. Right now, only two clinics have been operating for longer than 12 months, they are still maturing. For this first full year of activity we’re going for EUR2.1 million,” said Cristian Sas, the company’s chief operating officer.
A&D Pharma had combined turnover of almost EUR800 million last year through two of its largest firms: medicine distributor Mediplus and pharmacy network Sensiblu. In 2010, the group began developing a clinic network, which has grown to six units and a laboratory. No information is available on the group’s consolidated sales last year.
“This year, we opened three new units in the Aviatiei, Piata Presei and Militari areas. They required investments of around EUR1 million, reflected in the share capital, which has reached RON13.5 million lei (EUR3.2 million),” said Sas.
The company now employs more than 200 people, of whom 70% are physicians.
By the end of the year, Anima “probably won’t be able to open new units, as the focus is on growing its current units.” In 2012, plans for expansion will be made in accordance with the market’s development.
“We will definitely not stop here, but expansion depends first on the market and its evolution,” said Sas.
Anima now have over 43,000 subscriptions, most for occupational medicine, followed by employer plans, while individual plans account for about 20%.
“The sales of corporate, occupational and individual subscriptions are going very well. I cannot say the same thing about income from our relationship with the [Bucharest Health Insurance House], which in our case is 60% below expectations, having signed a contract with [the House] six months overdue,” said Sas.
Most of the company’s contracts are with Orange Romania, G4S, Intesa Sanpaolo, UniCredit, KPMG, Romtelecom, BRD.
Regarding this year’s trends on the private healthcare market, the head of Anima said the corporate segment is declining, while individual plans are gaining ground. Furthermore, said Sas, large companies have begun working with several healthcare providers, to give their employees more options, which has fragmented some big accounts.
The private healthcare market, which is worth close to EUR500,000, also includes MedLife, Medicover, Regina Maria, Euromedic, Sanador, Medsana, Polisano and others. Despite the crisis, these companies have continued expansion, which has brought in greater revenue every year.
After investing in clinics, they have now turned to hospitals. Hospitals worth more than EUR100 million were opened in the first six months of this year, according to ZF calculations based on data provided by the companies.
September saw new openings through the MedLife project in Brasov and more is in to follow.
Medas’ shareholders are looking at a EUR4 million hospital in Bucharest to treat urogenital problems.
(English version by Radu Bostan)